{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:49:14Z","timestamp":1791571754693,"version":"4.3.4"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    Restless legs syndrome (RLS) is a chronic neurological disorder associated with altered dopaminergic signaling, while long-term dopamine agonist therapy may be limited by augmentation and reduced clinical benefit. This study applied a three-dimensional convolutional neural network conditional variational autoencoder integrated with long short-term memory molecular generation to design rotigotine-derived candidates targeting dopamine D1 and D3 receptors. Fourteen unique derivatives were generated and screened through pocket prediction, molecular docking, interaction profiling, pharmacophore analysis, density functional theory, ADMET prediction, 500 ns molecular dynamics simulations performed in explicit water without a lipid bilayer, and MM\/GBSA calculations. Docking protocol validation using DockRMSD yielded RMSD values of 1.009 \u00c5 for Mevidalen in the D1 receptor and 1.359 \u00c5 for PD-128907 in the D3 receptor, supporting acceptable reproduction of both experimental binding poses. In docking-based ranking, AI Derivative 1 was placed above rotigotine for D1 (\u22125.744 vs \u22125.629 kcal\/mol) and D3 (\u22127.934 vs \u22127.288 kcal\/mol) and formed additional hydrogen-bond and hydrophobic contacts; the D1 difference of approximately 0.1 kcal\/mol lies within the intrinsic uncertainty of docking scoring functions and is not interpreted as evidence of improved affinity. Docking scores are used throughout as ranking and prioritization metrics rather than quantitative binding free energies. It also exhibited a smaller HOMO-LUMO gap, a higher predicted LD\n                    <jats:sub>50<\/jats:sub>\n                    , and a shift from toxicity class 3 to class 4. Molecular dynamics analyses, including RMSD, RMSF, radius of gyration, solvent-accessible surface area, hydrogen bonding, DCCM, PCA, and free-energy landscapes, are reported as descriptive observations from single non-membrane trajectories and are not used to claim physiological relevance or superior binding stability. MM\/GBSA estimates were favorable under the applied computational conditions. AI Derivative 1 therefore represents a computationally prioritized lead requiring experimental validation.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0356614","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:53:46Z","timestamp":1791568426000},"page":"e0356614","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["3D CNN-CVAE and LSTM-guided de novo design of rotigotine derivatives targeting dopamine D1 and D3 receptors in restless legs syndrome"],"prefix":"10.1371","volume":"21","author":[{"given":"Sinan","family":"Elia\u00e7\u0131k","sequence":"first","affiliation":[{"name":"Hitit University","place":["\u00c7orum, Turkey"],"department":["Department of Neurology, Faculty of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1979-7166","authenticated-orcid":true,"given":"Nouman","family":"Ali","sequence":"additional","affiliation":[{"name":"Rashid Latif Khan University","place":["Lahore, Punjab, Pakistan"],"department":["Department of Molecular Biosciences, Faculty of Physical and Biological Sciences"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"issue":"8","key":"pone.0356614.ref001","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/mds.30274","article-title":"Dopamine receptors in restless legs syndrome and augmentation: A novel perspective focused on D1 and D3 receptor dynamics","volume":"40","author":"S Clemens","year":"2025","journal-title":"Mov Disord"},{"issue":"1","key":"pone.0356614.ref002","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaf348","article-title":"Revisiting the mechanisms of dopamine receptor agonists in restless legs syndrome","volume":"49","author":"MP Mogavero","year":"2026","journal-title":"Sleep"},{"key":"pone.0356614.ref003","first-page":"229","article-title":"D3 receptors and restless legs syndrome.","volume-title":"Boileau I, Collo G, editors. Therapeutic applications of dopamine D3 receptor function: New insight after 30 years of research","author":"S Clemens","year":"2023"},{"issue":"10","key":"pone.0356614.ref004","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1474-4422(06)70576-2","article-title":"Less is more: Pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome","volume":"5","author":"W Paulus","year":"2006","journal-title":"Lancet Neurol"},{"key":"pone.0356614.ref005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/bs.apha.2019.01.002","article-title":"D3 and D1 receptors: The Yin and Yang in the treatment of restless legs syndrome with dopaminergics","volume":"84","author":"S Clemens","year":"2019","journal-title":"Adv Pharmacol"},{"issue":"4","key":"pone.0356614.ref006","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/bph.12988","article-title":"Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors","volume":"172","author":"M Wood","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"3","key":"pone.0356614.ref007","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.clinthera.2014.01.021","article-title":"From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome","volume":"36","author":"RK Bogan","year":"2014","journal-title":"Clin Ther"},{"key":"pone.0356614.ref008","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2018.00199","article-title":"Differential dopamine D1 and D3 receptor modulation and expression in the spinal cord of two mouse models of restless legs syndrome","volume":"12","author":"S Meneely","year":"2018","journal-title":"Front Behav Neurosci"},{"key":"pone.0356614.ref009","doi-asserted-by":"crossref","first-page":"108906","DOI":"10.1016\/j.compbiolchem.2026.108906","article-title":"AI-fragmented derivatives of methotrexate to design effective and safer DHFR inhibitor: A computational breakthrough for ectopic pregnancy therapy","volume":"122","author":"D Inan","year":"2026","journal-title":"Comput Biol Chem"},{"issue":"1","key":"pone.0356614.ref010","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1038\/s41598-026-41232-9","article-title":"AI fragmentation-based optimization of Sorafenib derivatives targeting VEGFR2 for angiogenesis-related pathologies: a structure-based in-silico study","volume":"16","author":"D Inan","year":"2026","journal-title":"Sci Rep"},{"issue":"6","key":"pone.0356614.ref011","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202502976","article-title":"AI\u2010driven optimization of cetirizine\u2010derived ligands targeting histamine H1 and H2 receptors: A computational drug design study","volume":"11","author":"M Naveed","year":"2026","journal-title":"ChemistrySelect"},{"issue":"6","key":"pone.0356614.ref012","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"J Vamathevan","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"pone.0356614.ref013","article-title":"Deep learning and artificial intelligence for drug discovery, application, challenge, and future perspectives","volume":"7","author":"N Ali","year":"2025","journal-title":"Discov Appl Sci"},{"issue":"1","key":"pone.0356614.ref014","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13321-025-01104-2","article-title":"VNFlow: integration of variational autoencoders and normalizing flows for novel molecular design","volume":"17","author":"J Hosta\u0161","year":"2025","journal-title":"J Cheminform"},{"issue":"3","key":"pone.0356614.ref015","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102295","article-title":"The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges","volume":"35","author":"C Chakraborty","year":"2024","journal-title":"Mol Therapy Nucleic Acids"},{"issue":"23","key":"pone.0356614.ref016","doi-asserted-by":"crossref","first-page":"23889","DOI":"10.1021\/acsomega.5c00549","article-title":"AI-driven drug discovery: A comprehensive review","volume":"10","author":"FJN Ferreira","year":"2025","journal-title":"ACS Omega"},{"issue":"9","key":"pone.0356614.ref017","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.3390\/pharmaceutics17091186","article-title":"Machine learning for multi-target drug discovery: Challenges and opportunities in systems pharmacology","volume":"17","author":"X Bi","year":"2025","journal-title":"Pharmaceutics"},{"issue":"1","key":"pone.0356614.ref018","doi-asserted-by":"crossref","first-page":"24906","DOI":"10.1038\/s41598-025-07574-6","article-title":"AI based natural inhibitor targeting RPS20 for colorectal cancer treatment using integrated computational approaches","volume":"15","author":"N Ali","year":"2025","journal-title":"Sci Rep"},{"key":"pone.0356614.ref019","doi-asserted-by":"crossref","first-page":"108606","DOI":"10.1016\/j.compbiolchem.2025.108606","article-title":"AI fragment based optimization of saffron and chamomile phytochemicals as aryl hydrocarbon receptor inhibitors for dementia therapy an integrated computational approach","volume":"120","author":"A Khan","year":"2026","journal-title":"Comput Biol Chem"},{"key":"pone.0356614.ref020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-0716-1406-8_1","article-title":"The protein data bank archive","volume":"2305","author":"S Velankar","year":"2021","journal-title":"Methods Mol Biol"},{"issue":"1","key":"pone.0356614.ref021","doi-asserted-by":"crossref","first-page":"16370","DOI":"10.1038\/s41598-026-45845-y","article-title":"Identification of natural FGFR3 inhibitor for glioma using integrated computational and microRNA regulatory analysis","volume":"16","author":"S Javaid","year":"2026","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0356614.ref022","doi-asserted-by":"crossref","first-page":"13462","DOI":"10.1038\/s41598-026-42662-1","article-title":"Computational screening of AI-derived cyclotides as putative VEGFR2 binders for wound-site angiogenesis","volume":"16","author":"\u00d6 Karaca Ocak","year":"2026","journal-title":"Sci Rep"},{"issue":"4","key":"pone.0356614.ref023","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00228148","article-title":"AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR","volume":"8","author":"RA Laskowski","year":"1996","journal-title":"J Biomol NMR"},{"issue":"1","key":"pone.0356614.ref024","doi-asserted-by":"crossref","first-page":"24565","DOI":"10.1038\/s41598-024-82302-0","article-title":"In silico investigation of ketamine and methylphenidate drug-drug conjugate for MDD and ADHD treatment using MD simulations and MMGBSA","volume":"15","author":"B Asrar","year":"2025","journal-title":"Sci Rep"},{"key":"pone.0356614.ref025","article-title":"PubChem substance and compound databases","volume":"44","author":"S Kim","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"pone.0356614.ref026","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.csbj.2021.06.017","article-title":"WADDAICA: A webserver for aiding protein drug design by artificial intelligence and classical algorithm","volume":"19","author":"Q Bai","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"pone.0356614.ref027","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1021\/acs.jcim.8b00706","article-title":"Shape-based generative modeling for de novo drug design","volume":"59","author":"M Skalic","year":"2019","journal-title":"J Chem Inf Model"},{"issue":"1","key":"pone.0356614.ref028","doi-asserted-by":"crossref","first-page":"28445","DOI":"10.1038\/s41598-024-79275-5","article-title":"Natural AI-based drug designing by modification of ascorbic acid and curcumin to combat buprofezin toxicity by using molecular dynamics study","volume":"14","author":"H Sadia","year":"2024","journal-title":"Sci Rep"},{"key":"pone.0356614.ref029","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf421","article-title":"PrankWeb 4: A modular web server for protein-ligand binding site prediction and downstream analysis","volume":"53","author":"L Pol\u00e1k","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"pone.0356614.ref030","doi-asserted-by":"crossref","first-page":"108606","DOI":"10.1016\/j.compbiolchem.2025.108606","article-title":"AI fragment based optimization of saffron and chamomile phytochemicals as aryl hydrocarbon receptor inhibitors for dementia therapy an integrated computational approach","volume":"120","author":"A Khan","year":"2026","journal-title":"Comput Biol Chem"},{"key":"pone.0356614.ref031","unstructured":"Jejurikar BL, Rohane SH. Drug designing in discovery studio. 2021."},{"issue":"1","key":"pone.0356614.ref032","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/ct300857j","article-title":"OpenMM 4: A reusable, extensible, hardware independent library for high performance molecular simulation","volume":"9","author":"P Eastman","year":"2013","journal-title":"J Chem Theory Comput"},{"key":"pone.0356614.ref033","article-title":"Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective","author":"N Guex","year":"2009","journal-title":"Electrophoresis"},{"key":"pone.0356614.ref034","first-page":"1000","article-title":"Using AutoDock 4 and AutoDock vina with AutoDockTools: a tutorial","author":"R Huey","year":"2012","journal-title":"The Scripps research institute molecular graphics laboratory"},{"issue":"1","key":"pone.0356614.ref035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13321-019-0362-7","article-title":"DockRMSD: An open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism","volume":"11","author":"EW Bell","year":"2019","journal-title":"J Cheminform"},{"key":"pone.0356614.ref036","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf361","article-title":"PLIP 2025: introducing protein-protein interactions to the protein-ligand interaction profiler","volume":"53","author":"P Schake","year":"2025","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pone.0356614.ref037","doi-asserted-by":"crossref","DOI":"10.1002\/wcms.1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"S Yuan","year":"2017","journal-title":"WIREs Comput Mol Sci"},{"key":"pone.0356614.ref038","unstructured":"Ali N, Naveed M, Waseem M, Majeed MN, Yolande Sandrine MN, Aloufi AS, et al. Structure-based drug discovery targeting fmhA in Staphylococcus warneri using extracts of Calliandra harrisii: an integrated ethnobotanical and in silico approach."},{"issue":"6","key":"pone.0356614.ref039","first-page":"1","article-title":"The pharmit backend: A computer systems approach to enabling interactive online drug discovery","volume":"62","author":"DR Koes","year":"2018","journal-title":"IBM J Res Dev"},{"issue":"03","key":"pone.0356614.ref040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1142\/S2737416523500631","article-title":"Assessment of melia azedarach plant extracts activity against hypothetical protein of Mycobacterium tuberculosis via GC-MS analysis and in silico approaches","volume":"23","author":"M Naveed","year":"2023","journal-title":"J Comput Biophys Chem"},{"key":"pone.0356614.ref041","doi-asserted-by":"crossref","first-page":"128715","DOI":"10.1016\/j.molstruc.2020.128715","article-title":"DFT studies on vibrational and electronic spectra, HOMO\u2013LUMO, MEP, HOMA, NBO and molecular docking analysis of benzyl-3-N-(2, 4, 5-trimethoxyphenylmethylene) hydrazinecarbodithioate","volume":"1220","author":"MA Mumit","year":"2020","journal-title":"J Mol Struct"},{"key":"pone.0356614.ref042","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"A Daina","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0356614.ref043","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41598-024-51954-3","article-title":"The natural breakthrough: phytochemicals as potent therapeutic agents against spinocerebellar ataxia type 3","volume":"14","author":"M Naveed","year":"2024","journal-title":"Sci Rep"},{"key":"pone.0356614.ref044","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: A webserver for the prediction of toxicity of chemicals","volume":"52","author":"P Banerjee","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pone.0356614.ref045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/jcs5020055","article-title":"On the use of molecular dynamics simulations for elucidating fine structural, physico-chemical and thermomechanical properties of lignocellulosic systems: Historical and future perspectives","volume":"5","author":"K Prasad","year":"2021","journal-title":"J Compos Sci"},{"issue":"3","key":"pone.0356614.ref046","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/app12031139","article-title":"Molecular dynamics of solids at constant pressure and stress using anisotropic stochastic cell rescaling","volume":"12","author":"V Del Tatto","year":"2022","journal-title":"Applied Sciences"},{"issue":"2","key":"pone.0356614.ref047","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/ph17020163","article-title":"Novel thiourea and oxime ether isosteviol-based anticoagulants: MD simulation and ADMET prediction","volume":"17","author":"M Gackowski","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"4","key":"pone.0356614.ref048","doi-asserted-by":"crossref","first-page":"29","DOI":"10.56782\/pps.379","article-title":"In silico screening and DFT analysis of nelumbo nucifera phytochemicals as potential BACE-1 inhibitors for Alzheimer\u2019s disease","volume":"23","author":"R Todkar","year":"2025","journal-title":"Prospect Pharm Sci"},{"issue":"6","key":"pone.0356614.ref049","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/pharmaceutics18060670","article-title":"Predicting blood-brain barrier permeability from experimental data: An interpretable and externally validated machine learning framework","volume":"18","author":"S Tiwari","year":"2026","journal-title":"Pharmaceutics"},{"issue":"8","key":"pone.0356614.ref050","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jama.2025.23247","article-title":"Restless legs syndrome: A review","volume":"335","author":"JW Winkelman","year":"2026","journal-title":"JAMA"},{"key":"pone.0356614.ref051","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.sleep.2015.10.006","article-title":"Management of augmentation of restless legs syndrome with rotigotine: A 1-year observational study","volume":"30","author":"C Trenkwalder","year":"2017","journal-title":"Sleep Med"},{"issue":"1","key":"pone.0356614.ref052","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaf305","article-title":"On the mechanisms of dopamine receptor agonists in restless legs syndrome","volume":"49","author":"S Ferr\u00e9","year":"2026","journal-title":"Sleep"},{"key":"pone.0356614.ref053","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ejmech.2018.01.017","article-title":"In vitro antiplasmodial efficacy of synthetic coumarin-triazole analogs","volume":"145","author":"N Yadav","year":"2018","journal-title":"European J Med Chem"},{"issue":"1","key":"pone.0356614.ref054","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12859-024-05962-9","article-title":"GPCR-BSD: a database of binding sites of human G-protein coupled receptors under diverse states","volume":"25","author":"F Liu","year":"2024","journal-title":"BMC Bioinform"},{"issue":"14","key":"pone.0356614.ref055","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1021\/acs.jmedchem.7b00693","article-title":"Probing the hydrophobic binding pocket of G-protein-coupled Lysophosphatidylserine receptor GPR34\/LPS1 by docking-aided structure-activity analysis","volume":"60","author":"M Sayama","year":"2017","journal-title":"J Med Chem"},{"key":"pone.0356614.ref056","doi-asserted-by":"crossref","first-page":"464715","DOI":"10.1016\/j.chroma.2024.464715","article-title":"A label-free strategy for immobilization of GPCRs using site-specific encoded non-natural amino acids to develop a selectively chromatographic approach for pursuing potential ligands binding to 5-hydroxytryptamine 1A receptor","volume":"1718","author":"X Zhao","year":"2024","journal-title":"J Chromatogr A"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:53:56Z","timestamp":1791568436000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356614"}},"subtitle":[],"editor":[{"given":"Ricky Bendanillo","family":"Nellas","sequence":"first","affiliation":[{"name":"UP Diliman: University of the Philippines Diliman","place":["PHILIPPINES"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0356614","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]}}}